Behandling med doxazosin har vist sig at medføre regression af venstre ventrikulære hypertrofi, ophobning af trombocytter samt forbedret kapacitet af vævsplasminogenaktivator.
Treatment with doxazosin has been shown to result in regression of left ventricular hypertrophy, inhibition of platelet aggregation as well as enhanced capacity of tissue plasminogen-activator.